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A Case of Eosinophilic Gastrointestinal
Disorders Presenting with Chronic
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Eosinophilic gastrointestinal disorders (EGID) are rare conditions characterized by eosinophilic infiltration of the bowel 
wall and gastrointestinal symptoms. These disorders can present with various manifestations, depending on the specific 
site of the affected gastrointestinal tract and specific layer of the affected gastrointestinal wall. The pathogenesis and 
etiology of EGID remain unclear. The present case report describes a 76-year-old woman who presented with chronic 
diarrhea and lower abdominal pain. The patient was successfully treated with corticosteroid and restriction of some food 
allergens. One needs to consider these rare disorders during the differential diagnosis of unexplained gastrointestinal 
symptoms, especially when they are associated with peripheral eosinophilia.
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￿erefore, family medicine doctors as primary physicians should 
be aware of systematic approaches and various experiences 
pertaining to this condition.
Eosinophilic gastrointestinal disorders (EGID) are one of 
rare causes of chronic diarrhea. The disorders are characterized 
by inflammation rich in eosinophilic infiltration in the gastro-
intestinal (GI)  tract without evidence of known causes for 
eosinophilia such as parasitic infection, drug reaction, or 
malignancy.
3-5) It was originally described by Kaijser
6) in 1937; 
since then, hundreds of cases have been described from all over 
the world including North America, Europe, Australia, and Asia.
7) 
Diverse cases of EGID have also been reported in Korea.
8,9) 
EGID can involve one or multiple segments of the GI tract 
from the esophagus to the rectum (mainly in the antrum of the 
stomach and small intestine),
10) and can also occupy various sites 
through the depth of the wall. Such inconsistency from case to 
case promotes unpredictable symptoms from pain to dysmotility, 
bleeding, obstruction, or ascites.
11)
About half of EGID cases present with allergic features, 
and some may be related to food allergy.
12) However, there are 
few reports of EGID associated with adults, especially with the 
INTRODUCTION
Chronic diarrhea is a common condition in primary care.
1) 
The various definitions of chronic diarrhea commonly include 
the presence of loose stools that last for at least 4 weeks. By one 
estimate, it occurs in up to 3-5% of population in United States.
2) 
Pathophysiologically, the major causes of chronic diarrhea include 
osmotic, secretory, in￿ammatory, and functional factors. Chronic 
diarrhea is a treatment challenge, even for experienced clinicians.
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colonoscopy. However, no speci￿c cause of the chronic diarrhea 
had been identified. One week previous to the current check-
up, the symptoms had recurred, which prompted the visit to our 
center. 
The patient had no personal and family history of allergic 
disorders such as asthma, atopy, allergic rhinitis, and other 
hypersensitivities, and denied any exposure to tobacco smoke, 
alcohol, drugs, herbal medications, and health functional foods. 
Laboratory ￿ndings were as follows: leukocyte count 8,800/mm
3 
(neutrophil, 40.5%; lymphocyte, 39.7%; eosinophil, 13.4%), 
total eosinophil count 1,180/mm
3 (normal range, 0 to 500/
mm
3), hemoglobin 9.7 g/dL (mean corpuscular volume, 95.3 
￿), erythrocyte sedimentation rate 21 mm/hour, and C-reactive 
protein 0.233 mg/dL. Biochemical tests were within normal 
limits other than protein (5.49 g/dL; normal range, 6.7 to 8.3 g/
dL) and albumin (2.74 g/dL; normal range, 3.8 to 5.0 g/dL). 
Stool was positive for occult blood and negative for ova and 
parasites. Upper GI endoscopy revealed mild antral gastritis. 
But, colonoscopy showed multifocal hyperemic edematous 
elderly.
13,14) ￿e present case report describes an elderly woman 
who presented with chronic diarrhea with lower abdominal 
pain. Marked improvement resulted from steroid therapy and 
restriction of some food allergens.
CASE REPORT
A 76-year-old woman visited our health promotion center 
for a health check-up with diarrhea, abdominal pain, and weight 
loss. About 2 years before, the patient had developed intermi￿ent 
watery diarrhea occurring after meals. Five months previous 
to the check-up, the diarrhea had become aggravated, with an 
average of 9 or 10 stool passages each day. Stool was yellowish and 
watery in character, and ended with bloody mucus with poignant 
lower abdominal pain. During this period, body weight decreased 
from 48 kg to 35 kg, and was accompanied by generalized 
weakness. The patient had been admitted to other hospitals 
several times and had received a medical check-up including a 
Figure 1. Colonoscopic findings. 
(A) Hyperemic edematous mu-
cosal change was evident on 
the descending colon. (B) Mild 
edematous mucosal change was 
noted on the sigmoid colon.
Figure 2. Pathologic findings. 
Endoscopic biopsy showing dif-
fuse infiltration of eosinophils 
and lymphocytes in the lamina 
propria on the descending colon. 
There are more than 20 eosi-
nophils per high power field (A, 
H&E ×200; B, H&E, ×400). Dong Ryul Lee: A Case of Eosinophilic Gastrointestinal Disorders Presenting with Chronic Diarrhea and Abdominal Pain
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days later, symptoms had markedly improved. One week later, 
the peripheral eosinophilia had resolved (239/mm
3). After 2 
weeks of treatment, steroid was tapered over a week. However, 
symptoms recurred, and cromolyn sodium and montelukast were 
tried to no avail.
According to the report that EGID are associated with food 
allergy,
12) the patient was instructed to maintain a food diary. 
Wheat, soy, and milk were suspected as allergens; restriction of 
these items from the diet produced a greater improvement in the 
absence of steroid use. ￿e patient has not had a clear relapse for 
5 months a￿er discharge and has gained 7 kg in weight. Currently, 
there is no limitation in activities of daily living, and the patient 
takes only low-dose of prednisolone (5 mg/day) intermittently 
for episodic mild diarrhea.
 DISCUSSION
EGID are rare conditions characterized by eosinophilic 
infil tration of the bowel wall and gastrointestinal symptoms.
3,4) 
In 1990, Talley et al.
15) defined EGID by three criteria: 1) 
the presence of gastrointestinal symptoms, 2) biopsies 
showing eosinophilic infiltration of one or more areas of the 
gastrointestinal tract from the esophagus to the colon, or 
characteristic radiological ￿ndings with peripheral eosinophilia, 
and 3) no evidence of parasitic or extraintestinal disease. 
Presently, this concept is most commonly used in de￿ning EGID.
In published reports, stomach (26-81%) and small intestine 
(28-100%) are the predominantly a￿ected sites but esophagus, 
large intestine, and rectum may be a￿ected as well.
7) 
EGID consist of heterogeneous subtypes including eosi-
no philic esophagitis, eosinophilic gastritis, eosinophilic gastro-
enteritis, and eosinophilic colitis. Although some researchers 
regard eosinophilic gastroenteritis as a synonym for EGID, 
others have used this term to refer to eosinophilic in￿ammation 
exclusively to the stomach and small intestine. To avoid redun-
dancy in this issue, this article restricted eosinophilic gastro-
enteritis as the la￿er.
16) 
EGID are exceedingly rare, lacking epidemiological data to 
estimate their true frequency. EGID a￿ect all races and ages, from 
infancy through adulthood, peaking during the second and sixth 
decades of life.
5) Contrary to other subtypes, eosinophilic colitis 
mucosa from the cecum to the sigmoid colon (Figure 1). 
Multiple random biopsies were taken. The pathologic findings 
revealed di￿use in￿ltration of eosinophils and lymphocytes in the 
lamina propria, especially on the descending colon (Figure 2). 
Abdominal computed tomography was unremarkable except for 
a simple renal cyst.
￿e patient was admi￿ed to our hospital for further evalua-
tion. On admission, the patient appeared chronically ill. Vital 
signs were stable including blood pressure (110/70 mm Hg), 
heart rate (74/minute), respiration rate (20/minute), and body 
temperature (36.5
oC). The conjunctiva was anemic and the 
sclera was anicteric. There was no cervical lymphadenopathy. 
On auscultation, the lung ￿elds were clear. Cardiac examination 
revealed no murmur or gallop. Abdominal examination re-
vealed hyperactive bowel sound and mild tenderness below 
the umbilicus. Extremities were not edematous or cyanotic. 
Neurological examination revealed no deficits or muscle weak-
ness.
Results of additional stool exam for leukocytes and fat were 
normal and stool culture was negative. Laboratory examination 
for anemia revealed ferritin 27.59 ng/mL, serum iron 26.39 ng/
dL, total iron-binding capacity 156.39 ng/dL, red cell distribution 
width 15.6%, and reticulocyte index 0.357. The results were 
consistent with iron de￿ciency anemia coexisting with anemia of 
chronic disease. 
As an additional evaluation for eosinophilia, tests for parasite 
specific antigens to Clonorchis, Paragonimus, Sparganum, and 
Cysticercus  were negative. Serological tests for connective tissue 
disease and vasculitis (rheumatoid factor, antinuclear antibody, 
lupus erythematosus test, and anti-neutrophil cytoplasmic 
antibody) were also negative. Total immunoglobulin E (IgE) 
was 46.63 IU/mL (normal range, 0 to 120 IU/mL) and multiple 
allergosorbent test (MAST) test for 35 allergens including soy, 
milk, wheat, and house dust mite was negative for all allergens.
After admission, the patient’s condition was improved by 
supportive care such as so￿ blend diet and parenteral hydration. 
However, symptoms recurred soon after discharge. Based 
on the symptoms of chronic diarrhea with lower abdominal 
pain, peripheral eosinophilia and eosinophilic infiltration on 
colonoscopic biopsy without any other causes, a diagnosis of 
EGID (subtype, eosinophilic colitis) was made. The patient 
received steroid therapy (prednisolone, 20 mg/day). Three Dong Ryul Lee: A Case of Eosinophilic Gastrointestinal Disorders Presenting with Chronic Diarrhea and Abdominal Pain
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has a bimodal age distribution, usually a￿ecting infants (mean age, 
60 days) and adolescents.
17) Although there are some di￿erences 
among the reports, the incidence is higher in males, with a ratio of 
3:2.
5)
The etiology of EGID remains largely unknown. Several 
studies have suggested a relationship with speci￿c food allergies, 
and approximately 70% of patients may have a personal or 
family history of allergic disorders such as asthma, hay fever, 
hypersensitivity to drugs, or eczema.
5) Thus, EGID may be 
associated with hypersensitivity reactions. Recent investigations 
have provided an insight into the pathogenesis of EGID, and 
support a critical role of allergens, eosinophils, mast cells, Th-2 
type cytokines (interleukin-3, -5, and -13), and eotaxin in 
mediating eosinophilic inﬂammation.
18) 
Although EGID are supposed to be related with hyper-
sensitivity, immunologic evidence of underlying allergy is 
lacking in most cases, except those mediated by IgE antibody, 
and typically EGID are present as immediate reactions or ac-
com panied by atopy or asthma. In contrast to other EGID, 
eosinophilic colitis is usually a non-IgE-associated disease. ￿us, 
skin prick test or antigen-specific IgE (RAST) is negative.
19)  
Some studies point to a T cell-mediated process, but the exact 
immunologic mechanisms for this have not been identified.
3,13) 
Similarly, the present case was normal in total and antigen-speci￿c 
IgE (MAST) and lacked immunologic evidence for allergy. But, 
dramatic improvement noted upon restriction of some foods 
provides strong evidence of a hypersensitivity reaction.
Signs and symptoms of EGID vary depending upon 
the location and layer of the involved gastrointestinal tissue. 
Classi￿cation of EGID by layer of GI involvement was proposed 
by Klein et al.
10) in 1970, and is currently the most referred in 
publi cation. Mucosal involvement is by far the most common, 
and is accompanied by one or more of the following symptoms: 
decreased appetite, nausea, vomiting, abdominal pain, diarrhea, 
GI bleeding, protein-losing enteropathy, anemia, and failure 
to thrive. Involvement of the muscular layer usually presents 
with colicky abdominal pain and symptoms of gastric outlet or 
intestinal obstruction. Serosal involvement, the least common, is 
accompanied by abdominal distention and eosinophilic ascites. 
Combinations of these symptoms occur with the involvement of 
more than one tissue layer.
￿e diagnosis of EGID requires a high index of suspicion, as 
the symptoms and presentations are nonspecific, often sharing 
features with more commonly encountered GI disorders, such 
as infection, inflammatory bowel diseases, and iatrogenic and 
functional GI disorders.
20) ￿ere are no con￿rmatory laboratory 
tests. Peripheral blood eosinophilia is suggestive of EGID, but 
is noted in only 60-80% of the patients.
21) Laboratory tests are 
useful in distinguishing EGID from other diseases associated with 
tissue eosinophilia. 
Endoscopic findings may be nonspecific and can include 
ery  thema, friability, ulcerations, erosions, nodules, and loss of 
vascularity.
4,7) Because normal-appearing mucosa can harbor 
eosinophilic in￿ltration and because of the patchy nature of these 
disorders with the exception of eosinophilic esophagitis, the 
diagnosis can be overlooked or remains in question if multiple 
biopsies are not taken. When biopsy specimens are evaluated and 
eosinophilic infiltration is identified, other causes of eosinophil 
in￿ltration must be excluded before the diagnosis is con￿rmed. 
As a result, it is all very common for patients with these disorders 
to be symptomatic for extended periods before an accurate 
diagnosis is made.
22)
Pathologic evaluation to prove eosinophilic infiltration is 
essential to confirm the diagnosis. Eosinophils are normally 
present in the lamina propria of the gut mucosa, except the 
esophagus.
4) ￿ere is generally no agreement on what constitutes 
a pathological number of eosinophils. In most of the publications 
involving large case series, a cut-o￿ of ≥20 eosinophils per high 
power field has been used to define EGID histologically.
14,15,23) 
In the present case, the tissue eosinophil numbers were also 
consistent with this definition. The diagnosis of the muscular 
form of EGID may require laparoscopic full-thickness biopsies. 
In eosinophilic colitis, there may be diffuse or focal aggregates 
in the lamina propria, crypt epithelium, and muscular mucosa 
preserving the underlying mucosal architecture.
22) 
The differential diagnosis of EGID includes secondary 
eosinophil-associated  GI disorders, such as hypereosinophilic 
syndromes, parasitic infections, inflammatory bowel diseases, 
celiac disease, food allergies, neoplasia, connective tissue dis-
orders (e.g., scleroderma and dermatomyositis) collagen 
vascular disorders (e.g., polyarteritis nodosa and Churg-Strauss 
syndrome), and use of medications.
4,5,7)
Evaluation for idiopathic hypereosinophilic syndrome (HES) 
in patients with apparent EGID is important.
3,7) Diagnostic Dong Ryul Lee: A Case of Eosinophilic Gastrointestinal Disorders Presenting with Chronic Diarrhea and Abdominal Pain
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Li￿le is known about the natural history of EGID as it has not 
yet been evaluated in longitudinal clinical studies. However, from 
currently available data and recent experience with eosinophilic 
colitis, EGID are considered to be chronic waxing and waning 
disorders.
22) Several studies have suggested an association between 
allergic  colitis and later development of inflammatory bowel 
disease (IBD), but this association is controversial.
17) Because 
these diseases can be predecessors to other disease processes, 
such as hypereosinophilic syndromes, routine endoscopic and 
cardiopulmonary evaluations are recommended.
3)
In the present case, the patient presented with chronic diar-
rhea and lower abdominal pain and EGID (eosinophilic colitis) 
was documented by eosinophilic infiltration on endoscopic 
biopsy and exclusion of secondary causes. ￿is patient was easily 
suspected of combined peripheral eosinophilia, but clinicians 
need to consider EGID as possible causes for chronic unexplained 
GI symptoms and take biopsies actively, although there are no 
characteristic endoscopic ￿ndings or peripheral eosinophilia. 
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